U.S. flag

An official website of the United States government

GTR Home > Genes

PSCA prostate stem cell antigen

Gene ID: 8000, updated on 5-Mar-2024
Gene type: protein coding
Also known as: PRO232; lncPSCA

Summary

This gene encodes a glycosylphosphatidylinositol-anchored cell membrane glycoprotein. In addition to being highly expressed in the prostate it is also expressed in the bladder, placenta, colon, kidney, and stomach. This gene is up-regulated in a large proportion of prostate cancers and is also detected in cancers of the bladder and pancreas. This gene includes a polymorphism that results in an upstream start codon in some individuals; this polymorphism is thought to be associated with a risk for certain gastric and bladder cancers. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2010]

Associated conditions

See all available tests in GTR for this gene

DescriptionTests
A genome-wide association study identifies two susceptibility loci for duodenal ulcer in the Japanese population.
GeneReviews: Not available
A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci.
GeneReviews: Not available
Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer.
GeneReviews: Not available
Genome-wide association study identifies multiple loci associated with bladder cancer risk.
GeneReviews: Not available

Genomic context

Location:
8q24.3
Sequence:
Chromosome: 8; NC_000008.11 (142670297..142682725)
Total number of exons:
4

Links

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.